Disruptive Science
Driven by Heart

Our mission is to develop novel therapeutics, bridging the innovation gap for patients in China and the world.

vline-orange
JIXING Announces the Grand Opening of the New Headquarter Office in China
vline-orange
JIXING Announces the First Patient Enrolled in China Cohort of Phase 3 Clinical Trial of Aficamten
vline-orange
JIXING Announces First Patients Enrolled in Phase 3 Clinical Study of OC-01 Nasal Spray in China

JIXING is a leading biotechnology company committed to bringing innovative science and medicines to underserved patients in China.

China Biotech

A differentiated China-based biotech with a patient-centric approach dedicated to improving outcomes in Cardiovascular and Ophthalmology.
Learn more

Strong Pipeline

A growing pipeline of high-quality, de-risked assets based on clinical results of our partners and with significant market potential in Greater China.
Learn more

World-class Team

A world-class team with strong clinical execution and regulatory experience.
Learn more

Strategic Partners

Founded and backed by RTW Investments, a leading global, full life-cycle healthcare investment firm and a proven company builder.
Learn more

22F, JC Plaza,
1225 Nanjing West Road,
Jing’an District, Shanghai 200040

+86-021-80311808

Copyright © 2022 JIXING Pharmaceuticals.
All Rights Reserved.
Privacy Notice | Terms of Use
沪公网安备 31010602006693号
Pipeline & Science
Our Expertise
Scroll to Top